The treatment of diabetic end-stage renal disease with peritoneal dialysis

被引：16

作者：

Feriani, M ^{[1
]}

Dell'Aquila, R ^{[1
]}

La Greca, G ^{[1
]}

机构：

[1] St Bortolo Hosp, Dept Nephrol, I-36100 Vicenza, Italy

来源：

关键词：

intraperitoneal insulin; osmotic agents; peritonitis;

D O I：

10.1093/ndt/13.suppl_8.53

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：53 / 56

页数：4

共 30 条

[1] ABRAHAM G, 1988, PERITON DIALYSIS INT, V8, P211
[2] Bargman J M, 1996, Perit Dial Int, V16 Suppl 1, pS211
[3] DEPAEPE M, 1983, PREVENTION TREATMENT, P299
[4] INSULIN DEGRADATION - MECHANISMS, PRODUCTS, AND SIGNIFICANCE
DUCKWORTH, WC
[J]. ENDOCRINE REVIEWS, 1988, 9 (03) : 319 - 345
[5] FLYNN CT, 1979, T AM SOC ART INT ORG, V25, P114
[6] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS - COMPARISON OF PATIENT MORTALITY WITH ADJUSTMENT FOR COMORBID CONDITIONS
HELD, PJ
PORT, FK
TURENNE, MN
GAYLIN, DS
HAMBURGER, RJ
WOLFE, RA
[J]. KIDNEY INTERNATIONAL, 1994, 45 (04) : 1163 - 1169
[7] HOLLEY J, 1991, PERITON DIALYSIS INT, V11, P347
[8] KESHAVIAH P, 1995, J AM SOC NEPHROL, V6, P540
[9] KHANNA R, 1994, TXB PERITONEAL DIALY, P639
[10] LINDBLAD AS, 1989, CONTINUOUS AMBULATOR